KAMEDIS CONSEILS

- Market Access Strategy Since 2008, KAMEDIS CONSEILS with its dual expertise in market access and health economic, is a partner supporting its customers in the market access strategy of their products with the various authorities ( ANSM , HAS, CEPS , DGOS ... ) , in many therapeutic areas. It is the development of a true relationship with the authorities on all clinical development of products but also with clini- cal experts, leading to a personalized strategy for each client. - Pricing and reimbursement, early access Writing of reimbursement dossiers ( drugs, medical devices , medical procedures) Writing of pricing dossiers Early market access strategies: ATU , access to innovation (PHRC , PRME , innovation package) Interviews with authorities ( ANSM ; CT, CNEDiMTS and CEESP of HAS; CEPS; DGOS; CNAMTS) : early meetings, negotiations and auditions Board of Experts - Health Economics Development of models: budget impact, cost-e ectiveness or cost utility, cost-minimization, cost-bene t Writing of cost-e ectiveness dossiers Development of health-economic arguments Writing of CSIS dossiers (Strategic Council of Health Industries) - Observational studies Implementation , monitoring and analysis of post-marketing , pharmaco-epidemiology and health economics studies Writing of clinical study reports - Our values Overview of the market access strategy in France ; Personalized partnership with pharmaceutical compa- nies in their market access strategy ; Key player with authorities and experts